232 related articles for article (PubMed ID: 32592806)
21. MC1568 Inhibits Thimerosal-Induced Apoptotic Cell Death by Preventing HDAC4 Up-Regulation in Neuronal Cells and in Rat Prefrontal Cortex.
Guida N; Laudati G; Mascolo L; Cuomo O; Anzilotti S; Sirabella R; Santopaolo M; Galgani M; Montuori P; Di Renzo G; Canzoniero LM; Formisano L
Toxicol Sci; 2016 Dec; 154(2):227-240. PubMed ID: 27660204
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis and biological evaluation of brain penetrant benzazepine-based histone deacetylase 6 inhibitors for alleviating stroke-induced brain infarction.
Guo Z; Zhang Z; Zhang Y; Wang G; Huang Z; Zhang Q; Li J
Eur J Med Chem; 2021 Jun; 218():113383. PubMed ID: 33799069
[TBL] [Abstract][Full Text] [Related]
23. Acetylation of p53 in the Cerebral Cortex after Photothrombotic Stroke.
Guzenko VV; Bachurin SS; Khaitin AM; Dzreyan VA; Kalyuzhnaya YN; Bin H; Demyanenko SV
Transl Stroke Res; 2023 Aug; ():. PubMed ID: 37580538
[TBL] [Abstract][Full Text] [Related]
24. Deactylase inhibitors disrupt cellular complexes containing protein phosphatases and deacetylases.
Brush MH; Guardiola A; Connor JH; Yao TP; Shenolikar S
J Biol Chem; 2004 Feb; 279(9):7685-91. PubMed ID: 14670976
[TBL] [Abstract][Full Text] [Related]
25. LMK235, a small molecule inhibitor of HDAC4/5, protects dopaminergic neurons against neurotoxin- and α-synuclein-induced degeneration in cellular models of Parkinson's disease.
Mazzocchi M; Goulding SR; Wyatt SL; Collins LM; Sullivan AM; O'Keeffe GW
Mol Cell Neurosci; 2021 Sep; 115():103642. PubMed ID: 34119632
[TBL] [Abstract][Full Text] [Related]
26. Involvement of HDAC6 in ischaemia and reperfusion-induced rat retinal injury.
Yuan H; Li H; Yu P; Fan Q; Zhang X; Huang W; Shen J; Cui Y; Zhou W
BMC Ophthalmol; 2018 Nov; 18(1):300. PubMed ID: 30453928
[TBL] [Abstract][Full Text] [Related]
27. Neuroprotective Effects of Selective Inhibition of Histone Deacetylase 3 in Experimental Stroke.
Matheson R; Chida K; Lu H; Clendaniel V; Fisher M; Thomas A; Lo EH; Selim M; Shehadah A
Transl Stroke Res; 2020 Oct; 11(5):1052-1063. PubMed ID: 32016769
[TBL] [Abstract][Full Text] [Related]
28. Inhibiting histone deacetylase 6 partly protects cultured rat cortical neurons from oxygen‑glucose deprivation‑induced necroptosis.
Yuan L; Wang Z; Liu L; Jian X
Mol Med Rep; 2015 Aug; 12(2):2661-7. PubMed ID: 25976407
[TBL] [Abstract][Full Text] [Related]
29. In cortical neurons HDAC3 activity suppresses RD4-dependent SMRT export.
Soriano FX; Hardingham GE
PLoS One; 2011; 6(6):e21056. PubMed ID: 21695276
[TBL] [Abstract][Full Text] [Related]
30. Repression of Transcriptional Activity of Forkhead Box O1 by Histone Deacetylase Inhibitors Ameliorates Hyperglycemia in Type 2 Diabetic Rats.
Cho HM; Seok YM; Lee HA; Song M; Kim I
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30424007
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of HDAC6 protects against rhabdomyolysis-induced acute kidney injury.
Shi Y; Xu L; Tang J; Fang L; Ma S; Ma X; Nie J; Pi X; Qiu A; Zhuang S; Liu N
Am J Physiol Renal Physiol; 2017 Mar; 312(3):F502-F515. PubMed ID: 28052874
[TBL] [Abstract][Full Text] [Related]
32. Nuclear translocation of histone deacetylase 4 induces neuronal death in stroke.
Yuan H; Denton K; Liu L; Li XJ; Benashski S; McCullough L; Li J
Neurobiol Dis; 2016 Jul; 91():182-93. PubMed ID: 26969532
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of histone deacetylase 3 by MiR-494 alleviates neuronal loss and improves neurological recovery in experimental stroke.
Zhao H; Li G; Zhang S; Li F; Wang R; Tao Z; Ma Q; Han Z; Yan F; Fan J; Li L; Ji X; Luo Y
J Cereb Blood Flow Metab; 2019 Dec; 39(12):2392-2405. PubMed ID: 31510852
[TBL] [Abstract][Full Text] [Related]
34. Vulnerability to opiate intake in maternally deprived rats: implication of MeCP2 and of histone acetylation.
Tesone-Coelho C; Morel LJ; Bhatt J; Estevez L; Naudon L; Giros B; Zwiller J; Daugé V
Addict Biol; 2015 Jan; 20(1):120-31. PubMed ID: 23980619
[TBL] [Abstract][Full Text] [Related]
35. HDAC6 inhibition results in tau acetylation and modulates tau phosphorylation and degradation in oligodendrocytes.
Noack M; Leyk J; Richter-Landsberg C
Glia; 2014 Apr; 62(4):535-47. PubMed ID: 24464872
[TBL] [Abstract][Full Text] [Related]
36. Developing selective histone deacetylases (HDACs) inhibitors through ebselen and analogs.
Wang Y; Wallach J; Duane S; Wang Y; Wu J; Wang J; Adejare A; Ma H
Drug Des Devel Ther; 2017; 11():1369-1382. PubMed ID: 28496307
[TBL] [Abstract][Full Text] [Related]
37. Differential regulation of Bdnf expression in cortical neurons by class-selective histone deacetylase inhibitors.
Koppel I; Timmusk T
Neuropharmacology; 2013 Dec; 75():106-15. PubMed ID: 23916482
[TBL] [Abstract][Full Text] [Related]
38. Selective HDAC6 inhibition prevents TNF-α-induced lung endothelial cell barrier disruption and endotoxin-induced pulmonary edema.
Yu J; Ma Z; Shetty S; Ma M; Fu J
Am J Physiol Lung Cell Mol Physiol; 2016 Jul; 311(1):L39-47. PubMed ID: 27190059
[TBL] [Abstract][Full Text] [Related]
39. Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation.
Dompierre JP; Godin JD; Charrin BC; Cordelières FP; King SJ; Humbert S; Saudou F
J Neurosci; 2007 Mar; 27(13):3571-83. PubMed ID: 17392473
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic therapy of cancer with histone deacetylase inhibitors.
Lakshmaiah KC; Jacob LA; Aparna S; Lokanatha D; Saldanha SC
J Cancer Res Ther; 2014; 10(3):469-78. PubMed ID: 25313724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]